Incyte (INCY) FY2013 results: revenue $355 million, up 19.5% on the year
Incyte Corp. (INCY) reported revenue of $355 million for fiscal 2013, the year ended 31 December 2013, up 19.5% on the year before. Net income was -$83 million, and diluted earnings per share $-0.56. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2014.
Revenue
$355 million
+19.5% on the year
FY2009FY2013
Operating margin
-4.5%
0.4% a year earlier
FY2009FY2013
Net income
-$83 million
FY2009FY2013
Diluted EPS
-$0.56
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
355
297
94.5
+19.5%
Cost of revenue
0.6
0.2
n/a
+301.3%
Gross profit
354
297
n/a
+19.3%
Gross margin
99.8%
99.9%
n/a
Research and development
260
210
179
+23.8%
Selling, general and administrative
110
85.4
58.2
+28.8%
Operating income
-16.1
1.1
-143
Operating margin
-4.5%
0.4%
-151.6%
Interest expense
38.7
46.1
43.8
-16.1%
Pre-tax income
-82.8
-44.1
-187
Income tax
0.3
0.2
n/a
+71.8%
Net income
-83.1
-44.3
-187
Net margin
-23.4%
-14.9%
-197.5%
Diluted EPS
-$0.56
-$0.34
-$1.49
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
9.2
-94.8
-162
Capital expenditure
4.3
2.8
3.8
+50.3%
Free cash flow
4.9
-97.7
-166
Free cash flow margin
1.4%
-32.9%
-175.2%
Depreciation and amortisation
29.2
30.0
27.0
-2.6%
Share-based compensation
38.4
38.5
29.0
-0.2%
Diluted shares, weighted
148m
n/a
125m
Shares outstanding at period end
163m
133m
126m
+22.1%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
-193
-175
-227
Debt
847
410
420
+106.5%
Other liabilities
n/a
95.4
136
Total liabilities and equity
630
330
329
+90.5%
Fixed assets
26.8
6.3
6.4
+322.9%
Intangible assets
17.5
n/a
n/a
Investments
37.6
4.4
4.4
+761.6%
Cash and equivalents
471
224
273
+110.4%
Inventory
0.4
0.3
n/a
+46.0%
Other assets
75.8
95.4
44.9
-20.5%
Total assets
630
330
329
+90.5%
10-K for the year ended 31 December 2013, filed 21 February 2014: the filing.